MNPR Chart
- 52-Week Range: $1.85 - $6.49
- Market Capitalization: $25.49M
- Short Percentage: 0%
- Target Price: $25.60
- Shares Outstanding: 12.62M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MNPR released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Monopar to Present at the 34th Annual Roth Conference and Maxim's 2022 Virtual Growth ConferenceGlobeNewsWire | March 8th
- Monopar Advances Dosing of Camsirubicin to Higher Level Than Tested In Any Previous Clinical TrialGlobeNewsWire | December 8th
- Monopar Therapeutics Reports Third Quarter 2021 Financial Results and Recent Clinical DevelopmentsGlobeNewsWire | November 12th
- Monopar Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business UpdatesGlobeNewsWire | August 12th
- Monopar Reaches Target Number of Clinical Sites in Phase 2b Portion of 2b/3 Validive® VOICE TrialGlobeNewsWire | August 5th
Company Info
Website: https://www.monopartx.com
Address: 1000 Skokie Boulevard, Wilmette, IL, United States, 60091
Sector: Healthcare
Industry: Biotechnology
Full time employees: 9
Address: 1000 Skokie Boulevard, Wilmette, IL, United States, 60091
Sector: Healthcare
Industry: Biotechnology
Full time employees: 9
$MNPR cover that shit
$MNPR Buy the dip
$MNPR PT?
$MNPR bears haha
$MNPR Stair stepping nicely
$MNPR Spike it!
$MNPR I like the stock!
$MNPR Silly Bears tricks are for kids